Illumina Cancer Genomics Summit

10:30am – 14:00pm • May 8
Precision Nexus Stage @ PrecisionMed Exhibition & Summit, Dubai World Trade Centre.

Get ready to immerse yourself in cutting-edge cancer research at the upcoming Illumina Cancer Genomics Summit in Dubai on May 8th, a highlight at the PrecisionMed Exhibition and Summit 2024.

Join leading experts from across the globe as they tackle the challenges and unveil the opportunities in precision oncology and revolutionary cancer management techniques. If you’re eager to deepen your understanding of precision medicine and the latest breakthroughs in cancer research, this summit is an absolute must.

Agenda

Time Presentation Speaker
 Session I: The Clinical Value of Comprehensive Genomic Profiling in Cancer  
10:30 – 11:00 Clinical Genomics Initiatives for Cancer Patients in the UAE Dr. Stephen Grobmyer, Chair of the Oncology Institute, Cleveland Clinic Abu Dhabi​
11:00 – 11:30 Insights from Genomic Profiling of Leukemias for Precision Medicine and Targeted Therapeutics​ Dr. Hussein Abbas, M.D. Anderson Cancer Center USA
11:30 – 12:00 Insights into Clinical Actionable Biomarkers in An Indian Cancer Cohort of 1000 Patients using Comprehensive Genomic Profiling Dr. Mithua Ghosh, Director, Clinical Diagnostics at Triesta Sciences, Health Care Global Enterprises ​India
Session II: The Role of Translational Research in Fighting Cancer  
12:00 – 12:20 Accelerating Cancer & Immuno-oncology Discoveries using Multiomics through the Illumina Ecosystem Dr. Sujash Chatterjee, Staff Marketing Manager, Global Market Development, Illumina
12:20 – 12:50 The Power of Single-Cell Analysis in Translational Research Dr. Hussein Abbas, M.D. Anderson Cancer Center USA
Session III: New Era for Cancer Prevention  
12:50 – 13:00 Single Gene Testing to Comprehensive Genomic Profiling (CGP) – Value for Clinical Labs, Health Care Providers and Cancer Patients in UAE

Dr. Faisal Khan​​, CEO of OncoHelix & Associate Professor at University of Calgary Canada

13:00 – 14:00 Panel Discussion : Current standard guidelines in the region, challenges, and opportunities for implementing precision oncology. Moderated by Dr. Boutros Maroun, Senior Manager, Medical Affairs, Illumina

Summit speakers

Dr. Stephen Grobmyer

Chair of the Oncology Institute, Cleveland Clinic Abu Dhabi

Dr. Faisal Khan

CEO of OncoHelix; Associate Professor, University of Calgary, Canada

Dr. Hussein A. Abbas, M.D., Ph.D.

Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center

Dr. Mithua Ghosh

Director, Clinical Diagnostics at Triesta Sciences, Health Care Global Enterprises ​India

Sujash Chatterjee

Global Market Development Lead, Cancer Research and Multiomics Applications, Illumina

Dr. Boutros Maroun

Senior Manager, Medical Affairs, Illumina

10:30am – 14:00pm • May 8
Precision Nexus Stage @ PrecisionMed Exhibition & Summit, Dubai World Trade Centre.